abstract |
The present invention relates to a selective depressant of phosphoinositide (PI) 3-kinase Beta, which is applied to the anti-thrombosis therapy, and a method of screening a compound used by a novel anti-thrombosis therapy by detecting the selective inhibitory activity of the PI 3-kinase Beta of the compound. |